Replies to post #234098 on Biotech Values

[DewDiligence]

RVNC 9/30/20_cash=$436M—decline_of_$58M since_6/30/20:

https://investors.revance.com/news-releases/news-release-details/revance-reports-third-quarter-2020-financial-results-and

The $58M cash burn in 3Q20 was inline with prior full-year guidance of $220-230M in operating expenses.